Literature DB >> 15016552

Simultaneous human papilloma virus type 16 E7 and cdk inhibitor p21 expression induces apoptosis and cathepsin B activation.

Dorte Wissing Kaznelson1, Silas Bruun, Astrid Monrad, Simon Gjerløv, Jesper Birk, Carsten Röpke, Bodil Norrild.   

Abstract

Human papillomavirus type 16 (HPV-16) is the major risk factor for development of cervical cancer. The major oncoprotein E7 enhances cell growth control. However, E7 has in some reports been shown to induce apoptosis suggesting that there is a delicate balance between cell proliferation and induction of cell death. We have used the osteosarcoma cell line U2OS cells provided with E7 and the cdk2 inhibitor p21 (cip1/waf1) under inducible control, as a model system for the analysis of E7-mediated apoptosis. Our data shows that simultaneous expression of E7 and p21 proteins induces cell death, possibly because of conflicting growth control. Interestingly, E7/p21-induced cell death is associated with the activation of a newly identified mediator of apoptosis, namely cathepsin B. Activation of the cellular caspases is undetectable in cells undergoing E7/p21-induced apoptosis. To our knowledge, this is the first time a role for cathepsin B is reported in HPV-induced apoptotic signalling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15016552     DOI: 10.1016/j.virol.2003.12.018

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

Review 1.  Mechanisms of human papillomavirus-induced oncogenesis.

Authors:  Karl Münger; Amy Baldwin; Kirsten M Edwards; Hiroyuki Hayakawa; Christine L Nguyen; Michael Owens; Miranda Grace; Kyungwon Huh
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

Review 2.  Modulation of apoptosis by human papillomavirus (HPV) oncoproteins.

Authors:  T O Garnett; P J Duerksen-Hughes
Journal:  Arch Virol       Date:  2006-07-27       Impact factor: 2.574

3.  Cystatin C deficiency promotes epidermal dysplasia in K14-HPV16 transgenic mice.

Authors:  Weifang Yu; Jian Liu; Michael A Shi; Jianan Wang; Meixiang Xiang; Shiro Kitamoto; Bing Wang; Galina K Sukhova; George F Murphy; Gabriela Orasanu; Anders Grubb; Guo-Ping Shi
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

4.  Rational Design of a Humanized Antibody Inhibitor of Cathepsin B.

Authors:  Zhefu Dai; Qinqin Cheng; Yong Zhang
Journal:  Biochemistry       Date:  2020-03-31       Impact factor: 3.162

Review 5.  Examination of the expanding pathways for the regulation of p21 expression and activity.

Authors:  Yong-Sam Jung; Yingjuan Qian; Xinbin Chen
Journal:  Cell Signal       Date:  2010-01-25       Impact factor: 4.315

6.  Dysregulation of macrophage-secreted cathepsin B contributes to HIV-1-linked neuronal apoptosis.

Authors:  Eillen J Rodriguez-Franco; Yisel M Cantres-Rosario; Marines Plaud-Valentin; Rafael Romeu; Yolanda Rodríguez; Richard Skolasky; Viviana Meléndez; Carmen L Cadilla; Loyda M Melendez
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

Review 7.  The modulation of apoptosis by oncogenic viruses.

Authors:  Alma Mariana Fuentes-González; Adriana Contreras-Paredes; Joaquín Manzo-Merino; Marcela Lizano
Journal:  Virol J       Date:  2013-06-06       Impact factor: 4.099

Review 8.  Regulation of apoptosis-associated lysosomal membrane permeabilization.

Authors:  Ann-Charlotte Johansson; Hanna Appelqvist; Cathrine Nilsson; Katarina Kågedal; Karin Roberg; Karin Ollinger
Journal:  Apoptosis       Date:  2010-05       Impact factor: 4.677

9.  Cysteine protease activation and apoptosis in Murine norovirus infection.

Authors:  Linnzi M Furman; Walid S Maaty; Lena K Petersen; Khalil Ettayebi; Michele E Hardy; Brian Bothner
Journal:  Virol J       Date:  2009-09-10       Impact factor: 4.099

Review 10.  Modulation of apoptotic pathways by human papillomaviruses (HPV): mechanisms and implications for therapy.

Authors:  Chung-Hsiang Yuan; Maria Filippova; Penelope Duerksen-Hughes
Journal:  Viruses       Date:  2012-12-18       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.